US Stocks
/
Xeris Biopharma Holdings, Inc. Share Price

Xeris Biopharma Holdings, Inc. Share Price

NASDAQ: XERS | Small Cap
$10.19
+$0.06 (0.59%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Xeris Biopharma Holdings, Inc. Stock Performance

Open
$10.01
Prev. Close
$10.13
Circuit Range
N/A
Day Range
$10.01 - $10.32
Year Range
$5.25 - $11.31
Volume
1,83,639
Average Traded
$10.19

Xeris Biopharma Holdings, Inc. Share Price Today

As of 9 October 2026, Xeris Biopharma Holdings, Inc.'s share price is $10.19. The stock opened at $10.01, compared to its previous close of $10.13. During today's trading session, Xeris Biopharma Holdings, Inc.'s share price traded between $10.01 and $10.32, with an average price of $10.17. Over the past 52 weeks, the stock has recorded a high of $11.31 and a low of $5.25. In terms of performance, Xeris Biopharma Holdings, Inc.'s share price has risen by 66.42% over the last six months and is up 5.11% on a year-on-year basis.

Xeris Biopharma Holdings, Inc. Share Price Chart

$10.01$10.32
L
Show Current Price
H

Xeris Biopharma Holdings, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.63B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.09
Revenue (TTM)
$291.85B
Return On Equity (TTM)
176.34%
Profit Margin
0.19%
Debt to Equity
-25.95
Quarterly Earnings Growth YoY
-5116.13%

Xeris Biopharma Holdings, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$74.38$85.81$83.13$92.10
Net Profit$0.62$11.08$2.23-$31.10
Net Profit Margin0.83%12.91%2.68%-33.77%
Income ChangeN/A1687.10%-79.87%-1494.62%

Xeris Biopharma Holdings, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$110.25$163.91$203.07$291.85
Net Profit-$94.66-$62.26-$54.84$0.55
Net Profit Margin-85.86%-37.98%-27.01%0.19%
Income ChangeN/A34.23%11.92%101.00%

About Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Xeris Biopharma Holdings, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$9.40
$10.21
+6.85%
Sep 2026
$8.49
$9.56
+11.16%
Aug 2026
$8.13
$8.60
+6.44%
Jul 2026
$7.95
$8.08
+2.02%
Jun 2026
$6.13
$7.92
+28.68%
May 2026
$6.17
$6.16
+0.57%
Apr 2026
$5.88
$6.12
+5.61%
Mar 2026
$6.98
$5.79
-5.16%
Feb 2026
$7.33
$6.11
-16.98%
Jan 2026
$7.85
$7.36
-6.12%
Dec 2025
$7.09
$7.84
+9.04%
Nov 2025
$9.59
$7.19
-25.80%

XERS Share Price FAQs

What is Xeris Biopharma Holdings, Inc. share price today?

chevron-up
Xeris Biopharma Holdings, Inc. share price today is $10.19 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Xeris Biopharma Holdings, Inc. stock?

chevron-up
The 52 week high of Xeris Biopharma Holdings, Inc. stock is $11.31, while the 52 week low is $5.25 as of 9 Oct '26.

What is XERS's market capitalisation today?

chevron-up
XERS market capitalisation is $1.63B as of October 9, 2026, at 5:17 am IST.

What is XERS's net income for the last quarter?

chevron-up
XERS's net income for the last quarter is -31.10B USD.

What is the 5 year returns of XERS?

chevron-up
The 5 year returns of XERS is 447.58% as on 9 Oct '26.

What is the high & low stock price of XERS today?

chevron-up
XERS stock price hit a high of $10.32 and low of $10.01 as of 9 Oct '26.

Can I buy XERS shares in India?

chevron-up
Yes. You can buy XERS in India by opening an international trading account.